← SynDRA
SB-415286
SynDRA canonical compound SYN1963617 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | GSK3A | GSK3B | RPS6KB1 |
|---|
| Mechanism of action | glycogen synthase kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- glycogen synthase kinase inhibitor
Cross-references
Synonyms
- SB 415286
- SB415286
- 3-(3-chloro-4-hydroxyphenylamino)-4-(2-nitrophenyl)-1H-pyrrole-2,5-dione
- 3-(3-chloro-4-hydroxyphenylamino)-4-(4-nitrophenyl)-1H-pyrrole-2,5-dione
- CHEMBL322970
- 3-(3-chloro-4-hydroxyanilino)-4-(2-nitrophenyl)pyrrole-2,5-dione
- 3-[(3-chloro-4-hydroxyphenyl)amino]-4-(2-nitrophenyl)-1H-pyrrole-2,5-dione
- 1H-Pyrrol-2,5-dione, 3-((3-chloro-4-hydroxyphenyl)amino)-4-(2-nitrophenyl)-
- SMR000568415
- SR-01000075855
Look up SB-415286 in the interactive SynDRA portal →